EWSR1 and Ewing sarcoma: Therefore, we decided to employ EWS shRNA plasmid (0.5 μg/ml) transfection and 100 μM TFL treatment alone and in combination for controlling growth of Ewing’s sarcoma cells in all subsequent experiments.